Ferenc Boldog
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Molecular Biology top 5%
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Renal and related cancers
- Protein Degradation and Inhibitors
Papers in
-
- Epigenetics and DNA Methylation 11
- Renal and related cancers 8
- CRISPR and Genetic Engineering 4
- Viral Infectious Diseases and Gene Expression in Insects 4
- Genetics 10
- Genetics and Neurodevelopmental Disorders 6
- Virus-based gene therapy research 3
- Co-authors
- Henri S. Lichenstein (7 shared papers)Michael Jeffers (5 shared papers)Harry A. Drabkin (8 shared papers)János Sümegi (10 shared papers)Rikard Erlandsson (9 shared papers)Robert M. Gemmill (6 shared papers)Craig Hackett (5 shared papers)Sigurður Ingvarsson (4 shared papers)
- Journals
- Genomics (5 papers)Proceedings of the National Academy of Sciences (3 papers)Human Molecular Genetics (2 papers)Genes Chromosomes and Cancer (2 papers)Biochemical Engineering Journal (1 paper)
- Partner nations
- United StatesSwedenRussia
In The Last Decade
Ferenc Boldog
36 papers receiving 2.4k citations
Ferenc Boldog's Hit Papers
Peers
Comparison fields: 5 of 103
- Cancer Research 445
- Molecular Biology 1.8k
- Oncology 517
- Genetics 500
- Cellular and Molecular Neuroscience 232
Countries citing papers authored by Ferenc Boldog
This map shows the geographic impact of Ferenc Boldog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferenc Boldog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferenc Boldog more than expected).
Fields of papers citing papers by Ferenc Boldog
This network shows the impact of papers produced by Ferenc Boldog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferenc Boldog. The network helps show where Ferenc Boldog may publish in the future.
Co-authors
The 25 scholars most cited alongside Ferenc Boldog, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors Hit paper breakdown → | 2007 | 599 |
| 2 | 2001 | 300 | |
| 3 | 1988 | 285 | |
| 4 | Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin. | 1996 | 177 |
| 5 | 2006 | 137 | |
| 6 | 1998 | 122 | |
| 7 | 1997 | 117 | |
| 8 | Angioarrestin: an antiangiogenic protein with tumor-inhibiting properties. | 2002 | 67 |
| 9 | 2005 | 63 | |
| 10 | 1994 | 59 | |
| 11 | 1993 | 58 | |
| 12 | 1996 | 51 | |
| 13 | Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis. | 2001 | 51 |
| 14 | The gene from the short arm of chromosome 3, at D3F15S2, frequently deleted in renal cell carcinoma, encodes acylpeptide hydrolase. | 1991 | 41 |
| 15 | 1997 | 34 | |
| 16 | 1990 | 33 | |
| 17 | 1994 | 32 | |
| 18 | A gene near the D3F15S2 site on 3p is expressed in normal human kidney but not or only at a severely reduced level in 11 of 15 primary renal cell carcinomas (RCC). | 1990 | 29 |
| 19 | 2013 | 27 | |
| 20 | 1991 | 22 |
About Ferenc Boldog
Ferenc Boldog is a scholar working on Molecular Biology, Genetics, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 36 papers that have together received 2.5k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (11 papers), Renal and related cancers (8 papers), Genetics and Neurodevelopmental Disorders (6 papers), Cancer Genomics and Diagnostics (5 papers), CRISPR and Genetic Engineering (4 papers), Renal cell carcinoma treatment (4 papers), Viral Infectious Diseases and Gene Expression in Insects (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Cancer Research (445 citations), Molecular Biology (1.8k citations), Oncology (517 citations), Genetics (500 citations) and Cellular and Molecular Neuroscience (232 citations). Ferenc Boldog has collaborated with scholars based in United States, Sweden and Russia. Frequent co-authors include Henri S. Lichenstein, Michael Jeffers, Harry A. Drabkin, János Sümegi, Rikard Erlandsson, Robert M. Gemmill, Craig Hackett, Sigurður Ingvarsson, Gunnar O. Klein and Gábor G. Kovács. Their work appears in journals such as Genomics, Proceedings of the National Academy of Sciences, Human Molecular Genetics, Genes Chromosomes and Cancer and Biochemical Engineering Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.